| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| LYPRESSIN DISCONTINUED (is an active metabolite)
| LYPRESSIN | HORMONES | NASAL | Cmax 1.1 NANOMOLAR VD 1370 LITER Cl 318 LITER / HOUR HT 3 HOUR | VASOPRESSIN V1 RECEPTOR VASOPRESSIN V2 RECEPTOR | VASOPRESSIN RECEPTOR AGONIST CHEMBL2363078 VASOPRESSIN RECEPTOR P30518 | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| TERLIPRESSIN (has an active metabolite)
| TERLIPRESSIN | HORMONE | INTRAVENOUS | Cmax 57.4 NANOMOLAR VD 6.3 LITER Cl 27.4 LITER / HOUR HT 0.9 HOUR | VASOPRESSIN V1 RECEPTOR VASOPRESSIN V2 RECEPTOR | VASOPRESSIN RECEPTOR AGONIST CHEMBL2363078 VASOPRESSIN RECEPTOR P30518 | EMA | |||
